How to achieve industry compliance within a highly regulated setting
Discover how a large UK pharmaceuticals manufacturer improved its data quality and real time reporting capabilities, as well as remaining compliant within a highly regulated industry
Pharmaceutical Manufacturing:
Enterprise Asset Management Within a Highly Regulated Industry
(This event has past - Tues Jan 26, 2021, 2:00 PM GMT)
You can still watch the webinar by clicking here
BPD Zenith - Explore some of the industry challenges faced by a large UK pharmaceuticals manufacturer in choosing to upgrade their IBM Maximo EAM solution. This included functionality for mobility, calibration and enhanced reporting - all within a strictly regulated and certified industry. Find out how this led to a reduction of 40% in unplanned work in just 6 months!
We explore the importance of data quality from its input source, through to live enhanced reporting, and how this was implemented as part of a business-critical upgrade.
Join BPD Zenith to discover:-
Modern EAM System Benefits
-
Creating an Optimised Mobile Workforce
-
Calibration
-
Business Intelligence Reporting
-
40% Reduction of Unplanned Work in just 6 months!
-
Delivered on time and within budget
More from BPD about the project...
Asset Management for Life Sciences
This paper outlines important strategic considerations for implementing asset
management in life sciences organizations. It also describes the IBM Maximo®
asset management solution for the life sciences industry
A Complete Life Sciences Solution
Employ a single-vendor solution that offers a risk-based approach for asset management to address Food and Drug Administration (FDA) regulations, including Good Manufacturing Practices (GMP) and FDA 21 CFR Part 11